Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age

OBJECTIVES: Levodopa–Carbidopa Intrajejunal gel (LCIG) infusion is an effective intervention for people with advanced Parkinson’s disease (PD). Although age may not be a limiting factor for LCIG implant, no data are available on late elderly PD (LE-PD) subjects. In this cross-sectional, we aimed to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neurol
Autores principales: Morgante, Francesca, Oppo, Valentina, Fabbri, Margherita, Olivola, Enrica, Sorbera, Chiara, De Micco, Rosa, Ielo, Giovanna Chiara, Colucci, Fabiana, Bonvegna, Salvatore, Novelli, Alessio, Modugno, Nicola, Sensi, Mariachiara, Zibetti, Maurizio, Lopiano, Leonardo, Tessitore, Alessandro, Pilleri, Manuela, Cilia, Roberto, Elia, Antonio E., Eleopra, Roberto, Ricciardi, Lucia, Cossu, Giovanni
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8068706/
https://ncbi.nlm.nih.gov/pubmed/33354739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-020-10356-x
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares